Stroke Risk May Be Reduced With Triglyceride-Lowering Medica

Stroke Risk May Be Reduced With Triglyceride-Lowering Medication As Adjunct Therapy


Stroke Risk May Be Reduced With Triglyceride-Lowering Medication As Adjunct Therapy
by Karishma Abhishek on 
March 14, 2021 at 10:08 AM
Risk of stroke can be lowered to an additional 36% in people at increased risk of cardiovascular disease and already on statin medications for reducing cholesterol, with the help of a triglyceride-lowering medication - icosapent ethyl, as presented by preliminary research at the
American Stroke Association's International Stroke Conference 2021.
"Icosapent ethyl is a new way to further reduce the risk of stroke in patients with atherosclerosis or who are at high risk of stroke, who have elevated triglyceride levels and are already taking statins," says Deepak L. Bhatt, M.D., M.P.H., lead author of the study and executive director of interventional cardiovascular programs at the Brigham and Women's Hospital Heart & Vascular Center in Boston.

Related Keywords

, Stroke , Stroke Risk , Cholesterol Lowering Medications , Cardiovascular Disease , Triglyceride Lowering Medication , Icosapent Ethyl , பக்கவாதம் , பக்கவாதம் ஆபத்து , கொழுப்பு குறைத்தல் மருந்துகள் , இருதய நோய் ,

© 2025 Vimarsana